Amredobresib is a potent inhibitor of BET. Amredobresib inhibits the binding of bromodomains to acetylated lysines on histone H3 and H4 and thus acts as important regulators of gene transcription. Amredobresib is useful for the research of acute myeloid
Molecular Weight:
467.57
Purity:
98.99
CAS Number:
[1610044-98-8]
Formula:
C26H29N9
Target:
Epigenetic Reader Domain
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted